Loading…
LifeScan has entered into an exclusive agreement with Sanvita Medical to market continuous glucose monitoring (CGM) sensors. The companies plan to launch CGM systems in North America and select European countries as early as mid-2020.
Johnson & Johnson accepted a binding offer from Platinum Equity to acquire its LifeScan business for approximately $2.1 billion. LifeScan is a blood glucose monitoring company and maker of OneTouch products.
Johnson & Johnson announced a binding offer from Platinum Equity to acquire its LifeScan business for approximately $2.1 billion. LifeScan is a leader in blood glucose monitoring products. The transaction is expected to close by the end of 2018.